These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 18424788)

  • 1. Far-field oversensing of atrial signals: an unusual cause for very short V-V intervals and inappropriate implantable cardioverter defibrillator therapy.
    Vollmann D; Lüthje L; Zabel M
    Europace; 2008 Aug; 10(8):1009-11. PubMed ID: 18424788
    [No Abstract]   [Full Text] [Related]  

  • 2. A life-threatening arrhythmia induced by inappropriate activation of an implantable cardioverter defibrillator.
    Kadmon E; Kusniec J; Strasberg B
    Europace; 2009 Dec; 11(12):1716-8. PubMed ID: 19762330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tools and strategies for the reduction of inappropriate implantable cardioverter defibrillator shocks.
    Tzeis S; Andrikopoulos G; Kolb C; Vardas PE
    Europace; 2008 Nov; 10(11):1256-65. PubMed ID: 18708639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unusual cause for an increase of the sensing integrity counter in a patient with inappropriate implantable cardioverter-defibrillator therapy.
    Vollmann D; Lüthje L; Zabel M
    Europace; 2007 May; 9(5):275-7. PubMed ID: 17369268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implantable cardiac defibrillator lead failure or myopotential oversensing? An approach to the diagnosis of noise on lead electrograms.
    Kowalski M; Ellenbogen KA; Wood MA; Friedman PL
    Europace; 2008 Aug; 10(8):914-7. PubMed ID: 18565976
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T-wave oversensing in implantable cardiac defibrillators is due to technical failure of device sensing.
    Gilliam FR
    J Cardiovasc Electrophysiol; 2006 May; 17(5):553-6. PubMed ID: 16684033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inappropriate defibrillator shocks from depolarization--repolarization mismatch in a patient with hypertrophy cardiomyopathy.
    Kapa S; Curwin JH; Coyne RF; Winters SL
    Pacing Clin Electrophysiol; 2007 Nov; 30(11):1408-11. PubMed ID: 17976109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential role of home monitoring to reduce inappropriate shocks in implantable cardioverter-defibrillator patients due to lead failure.
    Spencker S; Coban N; Koch L; Schirdewan A; Müller D
    Europace; 2009 Apr; 11(4):483-8. PubMed ID: 19103654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An unusual mechanism causing inappropriate implantable cardioverter defibrillator shocks: transient reduction in R-wave amplitude.
    Baranchuk A; Ribas S; Divakaramenon S; Morillo CA
    Europace; 2007 Aug; 9(8):694-6. PubMed ID: 17478463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inappropriate implantable cardioverter-defibrillator shock due to external alternating current leak: report of two cases.
    Chan NY; Wai-Ling Ho L
    Europace; 2005 Mar; 7(2):193-6. PubMed ID: 15763537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atrial tracking with a single ICD lead in the ventricle.
    Spears D; Selvaraj R; Dhopeswarkar R; Nanthakumar K
    J Cardiovasc Electrophysiol; 2008 Apr; 19(4):440-1. PubMed ID: 18298516
    [No Abstract]   [Full Text] [Related]  

  • 12. Inhibition of bradycardia pacing and detection of ventricular fibrillation due to far-field atrial sensing in a triple chamber implantable cardioverter defibrillator.
    Vollmann D; Lüthje L; Görtler G; Unterberg C
    Pacing Clin Electrophysiol; 2002 Oct; 25(10):1513-6. PubMed ID: 12418750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Downloadable algorithm to reduce inappropriate shocks caused by fractures of implantable cardioverter-defibrillator leads.
    Swerdlow CD; Gunderson BD; Ousdigian KT; Abeyratne A; Stadler RW; Gillberg JM; Patel AS; Ellenbogen KA
    Circulation; 2008 Nov; 118(21):2122-9. PubMed ID: 18981299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Non-functional lead as a cause of detection disturbances in implantable cardioverter-defibrillator].
    Kempa M; Budrejko S; Nowakowski M; Królak T; Daniłowicz-Szymanowicz L; Raczak G
    Kardiol Pol; 2012; 70(10):1073-5. PubMed ID: 23080104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resolution of T-wave oversensing with implantable cardioverter defibrillator generator replacement in an adolescent.
    Tuzcu V
    Pacing Clin Electrophysiol; 2007 Jul; 30(7):929-32. PubMed ID: 17584279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Results of a multicenter retrospective implantable cardioverter-defibrillator registry of pediatric and congenital heart disease patients.
    Berul CI; Van Hare GF; Kertesz NJ; Dubin AM; Cecchin F; Collins KK; Cannon BC; Alexander ME; Triedman JK; Walsh EP; Friedman RA
    J Am Coll Cardiol; 2008 Apr; 51(17):1685-91. PubMed ID: 18436121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T-wave oversensing and inappropriate shocks: a case report.
    Srivathsan K; Scott LR; Altemose GT
    Europace; 2008 May; 10(5):552-5. PubMed ID: 18442965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ventricular oversensing after replacement of an implantable cardioverter-defibrillator.
    Arias MA; Puchol A; Castellanos E; Pachón M; Rodríguez-Padial L
    Pacing Clin Electrophysiol; 2009 Jul; 32(7):925-7. PubMed ID: 19572871
    [No Abstract]   [Full Text] [Related]  

  • 19. Management of the patient with implantable cardioverter-defibrillator lead failure.
    Kalahasty G; Ellenbogen KA
    Circulation; 2011 Mar; 123(12):1352-4. PubMed ID: 21444893
    [No Abstract]   [Full Text] [Related]  

  • 20. Strategy to eliminate inappropriate shocks secondary to T-wave oversensing in a biventricular ICD.
    Silver JS; Gray ME; John RM
    Pacing Clin Electrophysiol; 2009 Jan; 32(1):134-6. PubMed ID: 19140924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.